文献速递肝病

2020年非酒精性脂肪性肝病:疾病现状综述

Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.
PubMed 文献 · Gastroenterology · 2020-02-13

非酒精性脂肪性肝病(NAFLD)是全球最常见的肝病,全球患病率为25%,美国NAFLD及非酒精性脂肪性肝炎(NASH)分别影响30%和5%的人口。肥胖与糖尿病流行将推高患病率及晚期肝病比例,NASH已接近成为肝移植最常见指征。综述更新了NAFLD的流行病学、临床与预后特征及无创诊断方法。

要点

  • 全球NAFLD患病率25%,美国NAFLD与NASH分别影响30%和5%人口。
  • NASH伴晚期纤维化者不良结局(总死亡率、肝脏相关并发症)风险显著增加。
  • 识别NASH及晚期纤维化患者是优化资源分配的关键,需借助无创工具。

核心结论

  • NAFLD是全球最常见肝病,患病率持续上升,NASH已接近成为肝移植最常见指征。
  • NASH伴晚期纤维化患者的不良结局风险显著增加,识别该人群至关重要。

研究设计与样本

  • 综述,未报告系统检索范围与样本量。

主要发现

  • 全球NAFLD患病率为25%,美国NAFLD患病率30%,NASH患病率5%。
  • NASH伴晚期纤维化患者总体死亡率及肝脏相关发病率与死亡率显著增加。

关键数值与推荐

  • 全球NAFLD患病率25%;美国NAFLD患病率30%,NASH患病率5%。
  • NASH伴晚期纤维化者不良结局风险显著增加。

临床怎么用

  • 临床应识别NAFLD患者中的NASH及晚期纤维化人群,以针对性分配资源。
  • 可应用无创工具评估NAFLD患者纤维化程度及预后风险。

局限性

  • 综述未报告系统检索策略、纳入研究数量及偏倚评估方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, with a worldwide prevalence of 25%. In the United States, NAFLD and its subtype, nonalcoholic steatohepatitis, affect 30% and 5% of the population, respectively. Considering the ongoing obesity epidemic beginning in childhood, the rise in diabetes, and other factors, the prevalence of NAFLD along with the proportion of those with advanced liver disease is projected to continue to increase. This will have an important impact on public health reflected in health care costs, including impact on the need for liver transplantation, for which nonalcoholic steatohepatitis is already close to becoming the most common indication. NAFLD patients with evidence of nonalcoholic steatohepatitis and advanced fibrosis are at markedly increased risk of adverse outcomes, including overall mortality, and liver-specific morbidity and mortality, respectively. Identification of this cohort of NAFLD patients is paramount, given the associated poorer outcomes, in order to target resources to those who need it most. Various noninvasive tools have been developed in this regard. This review provides an update on the epidemiology, clinical and prognostic features, and diagnostic approach to patients with NAFLD.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Cotter TG, Rinella M. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology. 2020. PMID: 32061595. doi:10.1053/j.gastro.2020.01.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。